
Amber D. Steele
Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1639, 1654, 1676, 1658 |
| Total Applications | 1278 |
| Issued Applications | 622 |
| Pending Applications | 159 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5331379
[patent_doc_number] => 20090111856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation'
[patent_app_type] => utility
[patent_app_number] => 12/299684
[patent_app_country] => US
[patent_app_date] => 2007-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5507
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299684
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299684 | Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation | May 6, 2007 | Abandoned |
Array
(
[id] => 4860487
[patent_doc_number] => 20080269337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Method for the enhancing biocidal activity'
[patent_app_type] => utility
[patent_app_number] => 11/796863
[patent_app_country] => US
[patent_app_date] => 2007-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3493
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11796863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/796863 | Method for the enhancing biocidal activity | Apr 29, 2007 | Abandoned |
Array
(
[id] => 9413679
[patent_doc_number] => 08697716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Method of inhibiting C-KIT kinase'
[patent_app_type] => utility
[patent_app_number] => 11/737517
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49869
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11737517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/737517 | Method of inhibiting C-KIT kinase | Apr 18, 2007 | Issued |
Array
(
[id] => 5436258
[patent_doc_number] => 20090170845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN'
[patent_app_type] => utility
[patent_app_number] => 12/296810
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12566
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296810 | USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAIN | Apr 12, 2007 | Abandoned |
Array
(
[id] => 9232864
[patent_doc_number] => 08598168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-03
[patent_title] => 'Inhibitors of histone deacetylase'
[patent_app_type] => utility
[patent_app_number] => 11/696880
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92598
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11696880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/696880 | Inhibitors of histone deacetylase | Apr 4, 2007 | Issued |
Array
(
[id] => 5284462
[patent_doc_number] => 20090098137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/294141
[patent_app_country] => US
[patent_app_date] => 2007-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15758
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098137.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294141 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER | Apr 4, 2007 | Abandoned |
Array
(
[id] => 5374750
[patent_doc_number] => 20090312311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'COMBINATION OF ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/225958
[patent_app_country] => US
[patent_app_date] => 2007-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13639
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312311.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225958
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225958 | COMBINATION OF ORGANIC COMPOUNDS | Apr 3, 2007 | Abandoned |
Array
(
[id] => 6038403
[patent_doc_number] => 20110091452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => '4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies'
[patent_app_type] => utility
[patent_app_number] => 12/294175
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16652
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091452.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294175
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294175 | 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies | Mar 29, 2007 | Abandoned |
Array
(
[id] => 6508412
[patent_doc_number] => 20100210635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'RENIN INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/294906
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 45149
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210635.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294906
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294906 | RENIN INHIBITORS | Mar 22, 2007 | Abandoned |
Array
(
[id] => 6007946
[patent_doc_number] => 20110059977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended'
[patent_app_type] => utility
[patent_app_number] => 12/294668
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6603
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294668
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294668 | USE OF CANTHIN-6-ONE AND ITS ANALOGS IN THE TREATMENT OF MYCOBACTERIA-LINKED PATHOLOGIES ( amended | Mar 21, 2007 | Abandoned |
Array
(
[id] => 4976781
[patent_doc_number] => 20070218012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Pharmaceutical Compositions'
[patent_app_type] => utility
[patent_app_number] => 11/687779
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18062
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11687779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/687779 | Pharmaceutical Compositions | Mar 18, 2007 | Abandoned |
Array
(
[id] => 4693151
[patent_doc_number] => 20080085922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'METHODS AND OPHTHALMIC DEVICES USED IN THE TREATMENT OF OCULAR ALLERGIES'
[patent_app_type] => utility
[patent_app_number] => 11/686979
[patent_app_country] => US
[patent_app_date] => 2007-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5448
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11686979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/686979 | Methods and ophthalmic devices used in the treatment of ocular allergies | Mar 15, 2007 | Issued |
Array
(
[id] => 5576054
[patent_doc_number] => 20090143416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Method of Inducing Tolerance of Plants Against Bacterioses'
[patent_app_type] => utility
[patent_app_number] => 12/223029
[patent_app_country] => US
[patent_app_date] => 2007-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7388
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143416.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223029 | Method of Inducing Tolerance of Plants Against Bacterioses | Mar 5, 2007 | Abandoned |
Array
(
[id] => 5447026
[patent_doc_number] => 20090048252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/281181
[patent_app_country] => US
[patent_app_date] => 2007-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40540
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048252.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281181 | THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS | Mar 1, 2007 | Abandoned |
Array
(
[id] => 5527838
[patent_doc_number] => 20090197915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'SIGMA RECEPTOR COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/281300
[patent_app_country] => US
[patent_app_date] => 2007-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19739
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281300 | Sigma receptor compounds | Mar 1, 2007 | Issued |
Array
(
[id] => 5291012
[patent_doc_number] => 20090023742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/281179
[patent_app_country] => US
[patent_app_date] => 2007-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25489
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023742.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281179 | THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS | Mar 1, 2007 | Abandoned |
Array
(
[id] => 5285584
[patent_doc_number] => 20090099259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Method for regulating gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/712102
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23528
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099259.pdf
[firstpage_image] =>[orig_patent_app_number] => 11712102
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/712102 | Method for regulating gene expression | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5297206
[patent_doc_number] => 20090012132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Pharmaceutical Package'
[patent_app_type] => utility
[patent_app_number] => 12/224363
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5579
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012132.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224363 | Pharmaceutical Package | Feb 25, 2007 | Abandoned |
Array
(
[id] => 7518926
[patent_doc_number] => 07973027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Compound with antimalarial activity and antimalarial drug containing the same as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/224387
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4533
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224387
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224387 | Compound with antimalarial activity and antimalarial drug containing the same as active ingredient | Feb 25, 2007 | Issued |
Array
(
[id] => 5005648
[patent_doc_number] => 20070203220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Inhibitors Of PAI-1 For Treatment Of Muscular Conditions'
[patent_app_type] => utility
[patent_app_number] => 11/679031
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21913
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679031 | Inhibitors Of PAI-1 For Treatment Of Muscular Conditions | Feb 25, 2007 | Abandoned |